Publication | Closed Access

Magnoflorine inhibits the malignant phenotypes and increases cisplatin sensitivity of osteosarcoma cells via regulating miR-410-3p/HMGB1/NF-κB pathway

Tumor BiologyCisplatin SensitivityOncologyMedicinePathologyCancer Cell BiologyOsteosarcoma CellsAnti-cancer AgentMicrorna DetectionCancer BiologyCell BiologyMir-410-3p/hmgb1/nf-κb PathwayCancer Research